SF3B2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.70620226017604E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.37340000003906E-07 |
Normal-vs-Stage2 |
1.28430000001512E-06 |
Normal-vs-Stage3 |
4.7839510131098E-13 |
Normal-vs-Stage4 |
4.11830000102142E-08 |
Stage1-vs-Stage2 |
8.289500E-02 |
Stage1-vs-Stage3 |
2.75159999996166E-06 |
Stage1-vs-Stage4 |
4.012500E-02 |
Stage2-vs-Stage3 |
1.287840E-01 |
Stage2-vs-Stage4 |
9.977400E-01 |
Stage3-vs-Stage4 |
7.911600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.32389654794451E-11 |
Normal-vs-AfricanAmerican |
2.683600E-03 |
Normal-vs-Asian |
4.173600E-02 |
Caucasian-vs-AfricanAmerican |
1.363230E-01 |
Caucasian-vs-Asian |
8.461000E-01 |
AfricanAmerican-vs-Asian |
6.796600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.28430640858824E-12 |
Normal-vs-Female |
1.0498000000414E-06 |
Male-vs-Female |
9.621800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.602940E-03 |
Normal-vs-Age(41-60Yrs) |
2.80380000328151E-08 |
Normal-vs-Age(61-80Yrs) |
1.57730051242311E-10 |
Normal-vs-Age(81-100Yrs) |
3.5673999999597E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.296000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.599000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.047000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.306400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.680000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.507190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.638800E-01 |
Normal-vs-Grade 2 |
3.55549999997429E-07 |
Normal-vs-Grade 3 |
4.72355488057019E-12 |
Normal-vs-Grade 4 |
1.18129994675087E-09 |
Grade 1-vs-Grade 2 |
1.695250E-03 |
Grade 1-vs-Grade 3 |
2.11729999999299E-05 |
Grade 1-vs-Grade 4 |
1.9565299999913E-05 |
Grade 2-vs-Grade 3 |
3.178300E-03 |
Grade 2-vs-Grade 4 |
8.396900E-03 |
Grade 3-vs-Grade 4 |
6.100800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.27839999994628E-06 |
Normal-vs-ccB subtype |
1.60440549734631E-11 |
ccA subtype-vs-ccB subtype |
4.30959999999647E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.29619989688956E-10 |
Normal-vs-N1 |
2.536600E-03 |
N0-vs-N1 |
9.638800E-01 |
|
|